74 related articles for article (PubMed ID: 26354014)
1. [Amyloid and tau imaging, its present and future].
Okamura N; Harada R; Kudo Y; Yanai K
Nihon Yakurigaku Zasshi; 2015 Sep; 146(3):144-9. PubMed ID: 26354014
[No Abstract] [Full Text] [Related]
2. Biomarkers reflecting different facets of Alzheimer's disease.
Zetterberg H
Eur J Neurol; 2008 Nov; 15(11):1143-4. PubMed ID: 18973609
[No Abstract] [Full Text] [Related]
3. The utility of the new research diagnostic criteria for Alzheimer's disease.
Dubois B; Gauthier S; Cummings J
Int Psychogeriatr; 2013 Feb; 25(2):175-7. PubMed ID: 23148941
[No Abstract] [Full Text] [Related]
4. [Biomarker and imaging of Alzheimer's disease].
Kawarabayashi T; Shoji M
No To Shinkei; 2005 Oct; 57(10):839-52. PubMed ID: 16277229
[No Abstract] [Full Text] [Related]
5. Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease.
Lehmann S; Delaby C; Paquet C; Gabelle A
Clin Chem Lab Med; 2015 Jul; 53(8):e175-7. PubMed ID: 25870963
[No Abstract] [Full Text] [Related]
6. Assessment of Tau Tangles and Amyloid-β Plaques Among Super Agers Using PET Imaging.
Hoenig MC; Willscheid N; Bischof GN; van Eimeren T; Drzezga A;
JAMA Netw Open; 2020 Dec; 3(12):e2028337. PubMed ID: 33306113
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease is getting easier to spot.
Dolgin E
Nature; 2018 Jul; 559(7715):S10-S12. PubMed ID: 30046081
[No Abstract] [Full Text] [Related]
8. Biomarkers: warning signs.
Williams R
Nature; 2011 Jul; 475(7355):S5-7. PubMed ID: 21760581
[No Abstract] [Full Text] [Related]
9. [Factors Influencing Brain Interstitial Fluid Concentrations of Amyloid β and Tau].
Kurihara M; Bannai T; Iwata A
Brain Nerve; 2020 May; 72(5):525-531. PubMed ID: 32381750
[TBL] [Abstract][Full Text] [Related]
10. Dementia diagnostics 2.0--transfer from research studies into routine clinical practice.
Otto M
Clin Chem; 2010 Feb; 56(2):152-3. PubMed ID: 19884484
[No Abstract] [Full Text] [Related]
11. Will CSF analysis become routine in people with memory complaints?
Gauthier S
Lancet Neurol; 2009 Jul; 8(7):595-6. PubMed ID: 19523878
[No Abstract] [Full Text] [Related]
12. Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.
Morris JC; Selkoe DJ
Neurobiol Aging; 2011 Dec; 32 Suppl 1():S1-3. PubMed ID: 22078168
[No Abstract] [Full Text] [Related]
13. [Tau imaging].
Kudo Y; Furumoto S; Harada R; Okamura N
Nihon Rinsho; 2016 Mar; 74(3):404-9. PubMed ID: 27025077
[TBL] [Abstract][Full Text] [Related]
14. [PET imaging of tau lesions].
Higuchi M
Nihon Yakurigaku Zasshi; 2015 May; 145(5):268. PubMed ID: 25958916
[No Abstract] [Full Text] [Related]
15. N,O-Benzamide difluoroboron complexes as near-infrared probes for the detection of β-amyloid and tau fibrils.
Chen Y; Yuan C; Xie T; Li Y; Dai B; Zhou K; Liang Y; Dai J; Tan H; Cui M
Chem Commun (Camb); 2020 Jul; 56(53):7269-7272. PubMed ID: 32475993
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of dementia: overview].
Furukawa K; Ishiki A; Tomita N; Arai H
Rinsho Shinkeigaku; 2014; 54(12):1171-3. PubMed ID: 25672736
[TBL] [Abstract][Full Text] [Related]
17. Development of Near-Infrared Fluorescent Probes for Use in Alzheimer's Disease Diagnosis.
Yang J; Zeng F; Ge Y; Peng K; Li X; Li Y; Xu Y
Bioconjug Chem; 2020 Jan; 31(1):2-15. PubMed ID: 31769660
[TBL] [Abstract][Full Text] [Related]
18. [Biomarker of dementia: clinical and preclinical diagnosis].
Shoji M
Nihon Rinsho; 2012 May; 70(5):857-63. PubMed ID: 22620013
[TBL] [Abstract][Full Text] [Related]
19. Detection and Quantification of β-Amyloid, Pyroglutamyl Aβ, and Tau in Aged Canines.
Schmidt F; Boltze J; Jäger C; Hofmann S; Willems N; Seeger J; Härtig W; Stolzing A
J Neuropathol Exp Neurol; 2015 Sep; 74(9):912-23. PubMed ID: 26247394
[TBL] [Abstract][Full Text] [Related]
20. [Clinical aspects of Alzheimer's disease].
Namba Y
Nihon Rinsho; 2004 Jan; 62 Suppl():61-5. PubMed ID: 15011321
[No Abstract] [Full Text] [Related]
[Next] [New Search]
